XRN2 and cancer: Taken together, data presented in Figure 3 and Figure 4 for A549 and MDA-MB-231 cancer cells clearly demonstrate that the concurrent depletion of XRN2 and PARPi exacerbate DSB formation at higher levels than each individual treatment alone and amplify the cellular stress response.